Brilliant breakdown of the hybrid model. The structured kill criteria approach is really interesting becasue it forces honest decision-making before capital gets wasted on dying assets. Most biotech vcs I know struggle with the emotional side of shutting things down even when the data clearly shows its time. Linking fundign to predefined scientific milestones instead of arbitrary timelines feels like such an obvious but underused strategy.
Brilliant breakdown of the hybrid model. The structured kill criteria approach is really interesting becasue it forces honest decision-making before capital gets wasted on dying assets. Most biotech vcs I know struggle with the emotional side of shutting things down even when the data clearly shows its time. Linking fundign to predefined scientific milestones instead of arbitrary timelines feels like such an obvious but underused strategy.